Results 101 to 110 of about 17,080,419 (148)

PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells. [PDF]

Oncol Rep
Geng Y, Zhou L, Lou Y, Chen J, Liu Q, Shen J, Yang Y, Wu W.   +7 more
europepmc   +1 more source

Functional Difference of MYC and MYCN in Combined Hepatocellular-Cholangiocarcinoma: Regulation of Differentiation by HNF1B. [PDF]

Cancer Sci
Goto M, Yamamoto M, Tanaka H, Fujii Y, Takasawa K, Kamikokura Y, Kamikokura M, Kobayashi N, Murakami T, Nishikawa Y, Takasawa A.   +10 more
europepmc   +1 more source

GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex. [PDF]

Int J Mol Sci
Lei X, Lang T, Li P, Wu C.
europepmc   +1 more source

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer. [PDF]

Cancer Drug Resist
Lai B, Xu C, Lai S, Zhou M, Kong H, Kong E, Yahaya BH.   +6 more
europepmc   +1 more source

Loss of TRPV1 may shift capsaicin response from MAPK-CASC11-MYC protection to mitochondrial apoptosis in glioblastoma U87 cells. [PDF]

Int J Biol Macromol
Chinreddy SR, Mashozhera NT, Lee G, Zaman I, Patel V, Harris RT, Hankins GR, Reddy UK.   +7 more
europepmc   +1 more source

Isolated signals in BCL2, MYC, BCL6, and DDIT3 FISH: implications for genetic alterations and protein dysregulation. [PDF]

Pathol Oncol Res
Wei Z, Chen Q, Feng Z, Tang F.
europepmc   +1 more source

Advancements and innovations in the molecular mechanisms and treatment of colorectal cancer. [PDF]

Discov Oncol
Wang X, Yang J.
europepmc   +1 more source

The eIF5-mimic protein 5MP1: a regulator of translation stringency and a multifaceted oncogene. [PDF]

J Biochem
Banerjee A, Brooke G, Ishiguro S, Asano K.   +3 more
europepmc   +1 more source

Myc and Skp2 overexpression promotes p27 ubiquitination and degradation in Ewing Sarcoma. [PDF]

PLoS One
Kubota Y, Kawano M, Itonaga I, Kaku N, Tanaka K.   +4 more
europepmc   +1 more source

SHP2 promotes osteosarcoma via regulating STAT3/TET3/HOXB2 signaling. [PDF]

Sci Rep
Yang H, Ji J.
europepmc   +1 more source